Schedule 13G ownership disclosure

CLOVIS ONCOLOGY INC

Security class unavailable · CUSIP: 189464100

Event date: 2018-06-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,801,127
Percent of class
9.1400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001306923-18-000015
Form type
SC 13G/A
Filer
Clovis Oncology, Inc.
CIK
CIK 1466301
Filed
Jun 25, 2018
Reporting period
Jun 14, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub